Bris­tol My­ers eyes ma­jor cuts; That $1B AI start­up; Phar­ma re­acts to Chi­na bill; Q1 earn­ings high­lights; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

It’s been quite a week with some big scoops from the End­points team, on top of what is shap­ing up to be an in­ter­est­ing earn­ings sea­son. See you next week as we track the biggest themes emerg­ing from me­dia and in­vestor calls.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER